Rainmed Medical Reports Stable Share Capital in May 2026 Monthly Return

Bulletin Express06-03

Rainmed Medical Limited released its Monthly Return for the period ended 31 May 2026, showing no changes to its authorised or issued share capital during the month. \n\nKey figures: \n• Authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 0.38 million. \n• Issued share count stayed flat at 1.40 billion ordinary shares; no treasury shares were held or cancelled. \n• Public float met the Main Board’s minimum 25% requirement, as confirmed by the company. \n\nShare-based incentives: \n• The Pre-IPO Share Option Scheme (granted 10 December 2021, exercise price HKD 3.90) had 21.72 million outstanding options at end-May 2026, unchanged from April. No shares were issued via option exercises, and no treasury shares were transferred. \n\nOther instruments: \n• No warrants, convertible securities or other arrangements to issue shares were reported for the month. \n\nOverall, Rainmed Medical’s share structure and public float remained unchanged in May 2026, indicating capital stability with potential dilution limited to existing unexercised options.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115532204?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115532204","market":"us","top_or_hot":-1,"title":"Rainmed Medical Reports Stable Share Capital in May 2026 Monthly Return","media":"Bulletin Express","content":"<p>Rainmed Medical Limited released its Monthly Return for the period ended 31 May 2026, showing no changes to its authorised or issued share capital during the month. \\n\\nKey figures: \\n• Authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 0.38 million. \\n• Issued share count stayed flat at 1.40 billion ordinary shares; no treasury shares were held or cancelled. \\n• Public float met the Main Board’s minimum 25% requirement, as confirmed by the company. \\n\\nShare-based incentives: \\n• The Pre-IPO Share Option Scheme (granted 10 December 2021, exercise price HKD 3.90) had 21.72 million outstanding options at end-May 2026, unchanged from April. No shares were issued via option exercises, and no treasury shares were transferred. \\n\\nOther instruments: \\n• No warrants, convertible securities or other arrangements to issue shares were reported for the month. \\n\\nOverall, Rainmed Medical’s share structure and public float remained unchanged in May 2026, indicating capital stability with potential dilution limited to existing unexercised options.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rainmed Medical Reports Stable Share Capital in May 2026 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRainmed Medical Reports Stable Share Capital in May 2026 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Rainmed Medical Limited released its Monthly Return for the period ended 31 May 2026, showing no changes to its authorised or issued share capital during the month. \\n\\nKey figures: \\n• Authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 0.38 million. \\n• Issued share count stayed flat at 1.40 billion ordinary shares; no treasury shares were held or cancelled. \\n• Public float met the Main Board’s minimum 25% requirement, as confirmed by the company. \\n\\nShare-based incentives: \\n• The Pre-IPO Share Option Scheme (granted 10 December 2021, exercise price HKD 3.90) had 21.72 million outstanding options at end-May 2026, unchanged from April. No shares were issued via option exercises, and no treasury shares were transferred. \\n\\nOther instruments: \\n• No warrants, convertible securities or other arrangements to issue shares were reported for the month. \\n\\nOverall, Rainmed Medical’s share structure and public float remained unchanged in May 2026, indicating capital stability with potential dilution limited to existing unexercised options.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02297","symbol_name":"润迈德-B","start_time":0,"source_url":"","article_id":"1115532204","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115532204","pubTimestamp":1780477556,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Rainmed Medical Limited released its Monthly Return for the period ended 31 May 2026, showing no changes to its authorised or issued share capital during the month. \\n\\nKey figures: \\n• Authorised...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02297":"润迈德-B"},"translate_title":"Rainmed Medical 2026年5月股本稳定月报表","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02297":1},"content_text":"Rainmed Medical Limited released its Monthly Return for the period ended 31 May 2026, showing no changes to its authorised or issued share capital during the month. \\n\\nKey figures: \\n• Authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 0.38 million. \\n• Issued share count stayed flat at 1.40 billion ordinary shares; no treasury shares were held or cancelled. \\n• Public float met the Main Board’s minimum 25% requirement, as confirmed by the company. \\n\\nShare-based incentives: \\n• The Pre-IPO Share Option Scheme (granted 10 December 2021, exercise price HKD 3.90) had 21.72 million outstanding options at end-May 2026, unchanged from April. No shares were issued via option exercises, and no treasury shares were transferred. \\n\\nOther instruments: \\n• No warrants, convertible securities or other arrangements to issue shares were reported for the month. \\n\\nOverall, Rainmed Medical’s share structure and public float remained unchanged in May 2026, indicating capital stability with potential dilution limited to existing unexercised options.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115532204","isCrawlerRequest":true}